TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
EXEL

Exelixis Inc

Healthcare · Biotechnology

58.20$ +0.4% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

Exelixis Inc (EXEL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 308 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow EXEL
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
117 11 69 120 271 240 211 49 290 334 252 308 1,183
6.3 6.5 6.4 7.3 7.5 7.6 7.3 7.3 7.4 6.9 6.9 7.0 28
40 24 19 25 23 26 26 36 31 20 29 33 113
135 – – – – – – – – – – – –
-25 24 -29 -146 58 104 17 -180 45 -73 -0.6 43 14
94 13 18 25 9.2 14 22 3.6 6.7 7.2 2.0 9.3 25
35 62 112 82 -217 -93 50 248 25 27 -51 91 93
-217 -209 -185 -264 -12 -190 -284 -302 -104 -258 -430 -323 -1,115
-220 -206 -184 -262 5.7 -188 -295 -316 -104 -255 -457 -344 -1,159
-68 -134 -3.4 -61 60 -41 -34 -19 212 106 -256 55 117
23 -2.6 51 95 262 226 189 45 284 326 250 298 1,158

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?